Percutaneous ankaferd injection to in vivo liver tissue in comparison to ethanol in an experimental rat model


Tas A., Koklu S., Beyazit Y., Karaca G., Astarci H. M. , Akbal E., ...More

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, vol.35, pp.549-553, 2011 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 35
  • Publication Date: 2011
  • Doi Number: 10.1016/j.clinre.2011.02.013
  • Title of Journal : CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY
  • Page Numbers: pp.549-553

Abstract

Aim: Percutaneous ethanol injection is an established management of nonresectable hepatocellular carcinoma (HCC) because of its high effectiveness and minimal invasiveness. However, ethanol has many disadvantages like less anti-tumoral necrotic effectivity, unequal permeation and local diffusion. The aim of this study is to compare hepatic tissue effects of percutaneous Ankaferd Blood Stopper (ABS) injection in comparison to ethanol in rat liver tissue.